Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)
A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing the Efficacy and Safety of Sarilumab Added to Non-biologic DMARD Therapy in Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intolerant of TNF-α Antagonists
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Mesquite, TX
To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)
A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing the Efficacy and Safety of Sarilumab Added to Non-biologic DMARD Therapy in Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intolerant of TNF-α Antagonists
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Mesquite, TX
Click here to add this to my saved trials
To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)
A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing the Efficacy and Safety of Sarilumab Added to Non-biologic DMARD Therapy in Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intolerant of TNF-α Antagonists
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Spokane, WA
To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)
A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing the Efficacy and Safety of Sarilumab Added to Non-biologic DMARD Therapy in Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intolerant of TNF-α Antagonists
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)
A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing the Efficacy and Safety of Sarilumab Added to Non-biologic DMARD Therapy in Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intolerant of TNF-α Antagonists
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Clarksburg, WV
To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)
A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing the Efficacy and Safety of Sarilumab Added to Non-biologic DMARD Therapy in Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intolerant of TNF-α Antagonists
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Clarksburg, WV
Click here to add this to my saved trials
To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)
A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing the Efficacy and Safety of Sarilumab Added to Non-biologic DMARD Therapy in Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intolerant of TNF-α Antagonists
Status: Enrolling
Updated:  11/16/2015
mi
from
Buenos Aires,
To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)
A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing the Efficacy and Safety of Sarilumab Added to Non-biologic DMARD Therapy in Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intolerant of TNF-α Antagonists
Status: Enrolling
Updated: 11/16/2015
mi
from
Buenos Aires,
Click here to add this to my saved trials
Wearable Therapeutic Ultrasound Study for Knee Osteoarthritis
Wearable Therapeutic Ultrasound Study
Status: Enrolling
Updated:  11/17/2015
UpState Orthopedics
mi
from
East Syracuse, NY
Wearable Therapeutic Ultrasound Study for Knee Osteoarthritis
Wearable Therapeutic Ultrasound Study
Status: Enrolling
Updated: 11/17/2015
UpState Orthopedics
mi
from
East Syracuse, NY
Click here to add this to my saved trials
Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
A Multicenter, Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
Status: Enrolling
Updated:  11/19/2015
Children's Hospital
mi
from
New Orleans, LA
Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
A Multicenter, Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
Status: Enrolling
Updated: 11/19/2015
Children's Hospital
mi
from
New Orleans, LA
Click here to add this to my saved trials
Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
A Multicenter, Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
Status: Enrolling
Updated:  11/19/2015
Floating Hospital for Children at Tufts Medical Center
mi
from
Boston, MA
Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
A Multicenter, Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
Status: Enrolling
Updated: 11/19/2015
Floating Hospital for Children at Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
A Multicenter, Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
Status: Enrolling
Updated:  11/19/2015
UMASS Memorial Children's Medical Center
mi
from
Worcester, MA
Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
A Multicenter, Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
Status: Enrolling
Updated: 11/19/2015
UMASS Memorial Children's Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
A Multicenter, Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
Status: Enrolling
Updated:  11/19/2015
Altoona Center for Clinical Research Altoona Arthritis
mi
from
Duncansville, PA
Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
A Multicenter, Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
Status: Enrolling
Updated: 11/19/2015
Altoona Center for Clinical Research Altoona Arthritis
mi
from
Duncansville, PA
Click here to add this to my saved trials
Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
A Multicenter, Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
Status: Enrolling
Updated:  11/19/2015
Dell Children's Medical Center of Central Texas
mi
from
Austin, TX
Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
A Multicenter, Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
Status: Enrolling
Updated: 11/19/2015
Dell Children's Medical Center of Central Texas
mi
from
Austin, TX
Click here to add this to my saved trials
Activity, Rheumatoid and Osteoarthritis, and Weight Management
Weight Management, Physical Activity, Less Disability in Rheumatoid and Osteoarthritis
Status: Enrolling
Updated:  11/25/2015
Park Nicollet Institute
mi
from
St Louis Park, MN
Activity, Rheumatoid and Osteoarthritis, and Weight Management
Weight Management, Physical Activity, Less Disability in Rheumatoid and Osteoarthritis
Status: Enrolling
Updated: 11/25/2015
Park Nicollet Institute
mi
from
St Louis Park, MN
Click here to add this to my saved trials
Wearable Sensor-based Balance Training for Patients With Knee Osteoarthritis
Explore the Effectiveness of a Sensor-based Interactive Exercise Training on Functional Performance in Patients With Knee Osteoarthritis
Status: Enrolling
Updated:  11/30/2015
University of Arizona Arthritis Center
mi
from
Tucson, AZ
Wearable Sensor-based Balance Training for Patients With Knee Osteoarthritis
Explore the Effectiveness of a Sensor-based Interactive Exercise Training on Functional Performance in Patients With Knee Osteoarthritis
Status: Enrolling
Updated: 11/30/2015
University of Arizona Arthritis Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  12/1/2015
Clinical Research Facility
mi
from
Huntsville, AL
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 12/1/2015
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  12/1/2015
Clinical Research Facility
mi
from
Gilbert, AZ
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 12/1/2015
Clinical Research Facility
mi
from
Gilbert, AZ
Click here to add this to my saved trials
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  12/1/2015
Clinical Research Facility
mi
from
Phoenix, AZ
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 12/1/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  12/1/2015
Clinical Research Facility
mi
from
Murrieta, CA
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 12/1/2015
Clinical Research Facility
mi
from
Murrieta, CA
Click here to add this to my saved trials
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  12/1/2015
Clinical Research Facility
mi
from
Miami Lakes, FL
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 12/1/2015
Clinical Research Facility
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  12/1/2015
Clinical Research Facility
mi
from
Lenexa, KA
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 12/1/2015
Clinical Research Facility
mi
from
Lenexa, KA
Click here to add this to my saved trials
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  12/1/2015
Clinical Research Facility
mi
from
Frederick, MD
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 12/1/2015
Clinical Research Facility
mi
from
Frederick, MD
Click here to add this to my saved trials
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  12/1/2015
Clinical Research Facility
mi
from
Worcester, MA
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 12/1/2015
Clinical Research Facility
mi
from
Worcester, MA
Click here to add this to my saved trials
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  12/1/2015
Clinical Research Facility
mi
from
Kalamazoo, MI
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 12/1/2015
Clinical Research Facility
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  12/1/2015
Clinical Research Facility
mi
from
Albuquerque, NM
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 12/1/2015
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  12/1/2015
Clinical Research Facility
mi
from
Charlotte, NC
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 12/1/2015
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  12/1/2015
Clinical Research Facility
mi
from
Raleigh, NC
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 12/1/2015
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  12/1/2015
Clinical Research Facility
mi
from
Salisbury, NC
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 12/1/2015
Clinical Research Facility
mi
from
Salisbury, NC
Click here to add this to my saved trials
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  12/1/2015
Clinical Research Facility
mi
from
Wyomissing, PA
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 12/1/2015
Clinical Research Facility
mi
from
Wyomissing, PA
Click here to add this to my saved trials
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  12/1/2015
Clinical Research Facility
mi
from
Jackson, TN
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 12/1/2015
Clinical Research Facility
mi
from
Jackson, TN
Click here to add this to my saved trials
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  12/1/2015
Clinical Research Facility
mi
from
Austin, TX
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 12/1/2015
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  12/1/2015
Clinical Research Facility
mi
from
Houston, TX
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 12/1/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  12/1/2015
Clinical Research Facility
mi
from
Franklin, WI
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 12/1/2015
Clinical Research Facility
mi
from
Franklin, WI
Click here to add this to my saved trials
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  12/1/2015
mi
from
Plovdiv,
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 12/1/2015
mi
from
Plovdiv,
Click here to add this to my saved trials
Risk of Falling After CFNB Versus ACB
Comparison Between the Risk Falls After Total Knee Arthroplasty With Use of Femoral Nerve Block Versus Adductor Canal Block
Status: Enrolling
Updated:  12/1/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Risk of Falling After CFNB Versus ACB
Comparison Between the Risk Falls After Total Knee Arthroplasty With Use of Femoral Nerve Block Versus Adductor Canal Block
Status: Enrolling
Updated: 12/1/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
Achieve Clinical Research
mi
from
Birmingham, AL
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
Achieve Clinical Research
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
Desert Medical Advances
mi
from
Palm Desert, CA
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
Desert Medical Advances
mi
from
Palm Desert, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
Bay Area Arthritis and Osteoporosis
mi
from
Brandon, FL
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
Bay Area Arthritis and Osteoporosis
mi
from
Brandon, FL
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
Health Point Medical Group
mi
from
Brandon, FL
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
Health Point Medical Group
mi
from
Brandon, FL
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
Palmetto Medical Research
mi
from
Hialeah, FL
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
Palmetto Medical Research
mi
from
Hialeah, FL
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
Suncoast Clinical Research, Inc.
mi
from
New Port Richey, FL
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
Suncoast Clinical Research, Inc.
mi
from
New Port Richey, FL
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
University of South Florida
mi
from
Tampa, FL
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
Coeur D'Alene Arthritis Clinic
mi
from
Coeur D'Alene, ID
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
Coeur D'Alene Arthritis Clinic
mi
from
Coeur D'Alene, ID
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
Rockford Orthopedic Associates, LTD
mi
from
Rockford, IL
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
Rockford Orthopedic Associates, LTD
mi
from
Rockford, IL
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
Advanced Rheumatology
mi
from
Lansing, MI
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
Advanced Rheumatology
mi
from
Lansing, MI
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
Heartland Clinical Research, Inc.
mi
from
Omaha, NE
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
Heartland Clinical Research, Inc.
mi
from
Omaha, NE
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
Physician's East
mi
from
Greenville, NC
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
Physician's East
mi
from
Greenville, NC
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
Altoona Center for Clinical Research
mi
from
Duncansville, PA
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
Altoona Center for Clinical Research
mi
from
Duncansville, PA
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
West Tennessee Research Institute
mi
from
Jackson, TN
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
West Tennessee Research Institute
mi
from
Jackson, TN
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
Ramesh C. Gupta, M.D.
mi
from
Memphis, TN
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
Ramesh C. Gupta, M.D.
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
Baylor Research Institute
mi
from
Dallas, TX
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
Baylor Research Institute
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
Arthritis & Osteoporosis Associates, LLP
mi
from
Lubbock, TX
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
Arthritis & Osteoporosis Associates, LLP
mi
from
Lubbock, TX
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
University of Utah
mi
from
Salt Lake City, UT
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials